Stage-specific digital health technology biomarkers enhance diagnostic and early progression detection in Parkinson’s disease - Poll - MDSpire

Stage-specific digital health technology biomarkers enhance diagnostic and early progression detection in Parkinson’s disease

  • By

  • Matthew D. Czech

  • Samantha Sawicki

  • Cindy Zadikoff

  • Chengcheng Liu

  • Weining Robieson

  • Ying Liu

  • Weihua Shi

  • Jie Shen

  • Michelle Crouthamel

  • Maria S. Quinton

  • Josh Cosman

  • E. Ray Dorsey

  • Jamie L. Adams

  • Naomi Nevler

  • July 8, 2026

  • 0 min

Share

Original Source(s)

Stage-specific digital health technology biomarkers enhance diagnostic and early progression detection in Parkinson’s disease

  • by Matthew D. Czech, Samantha Sawicki, Cindy Zadikoff, Chengcheng Liu, Weining Robieson, Ying Liu, Weihua Shi, Jie Shen, Michelle Crouthamel, Maria S. Quinton, Josh Cosman, E. Ray Dorsey, Jamie L. Adams, Naomi Nevler

  • July 8, 2026

Related Content

Head-to-Head Trial in Relapsing MS

The phase 3 OVERLORD-MS trial compared 2 anti-CD20 therapies in previously untreated adults with newly diagnosed relapsing multiple sclerosis and recent inflammatory disease activity.

Harmonization of social and physical health measures across prospective clinical studies of combat exposed service members and veterans: the total brain diagnostics program

Videofluoroscopic swallow study in dysphagia stroke patients